{
    "organizations": [],
    "uuid": "77d2138fb80359e9b4b8a08cc90651014854e3c4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-genocea-qtrly-loss-per-share-037/brief-genocea-qtrly-loss-per-share-0-37-idUSASB0C5YJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Genocea Qtrly Loss Per Share $0.37",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 15, 2018 / 1:18 PM / in 6 minutes BRIEF-Genocea Qtrly Loss Per Share $0.37 Reuters Staff Feb 15 (Reuters) - Genocea Biosciences Inc: * GENOCEA REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS * GENOCEA BIOSCIENCES - EXPECTS EXISTING CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO SUPPORT ITS OPERATING EXPENSES & CAPEX REQUIREMENTS INTO H2 OF 2019 * GENOCEA BIOSCIENCES INC QTRLY LOSS PER SHARE $0.37 Source text for Eikon: Further company coverage:",
    "published": "2018-02-15T15:15:00.000+02:00",
    "crawled": "2018-02-15T15:43:12.069+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "qtrly",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "genocea",
        "bioscience",
        "inc",
        "genocea",
        "report",
        "fourth",
        "quarter",
        "financial",
        "result",
        "genocea",
        "bioscience",
        "expects",
        "existing",
        "cash",
        "cash",
        "equivalent",
        "sufficient",
        "support",
        "operating",
        "expense",
        "capex",
        "requirement",
        "h2",
        "genocea",
        "bioscience",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}